BOTOX®
BOTOX® is a biological therapy with 95 clinical trials. Currently 2 active trials ongoing. Historical success rate of 89.7%.
Success Metrics
Based on 70 completed trials
Phase Distribution
Phase Distribution
23
Early Stage
15
Mid Stage
43
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.3%
70 of 83 finished
15.7%
13 ended early
2
trials recruiting
95
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor
A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence
A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult Participants
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine
Clinical Trials (95)
A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor
A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence
A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult Participants
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine
A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial Lines
A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants
A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult Participants
A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants
Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment
Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines
Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a
Double-blind Comparative Randomized Multicenter
Female Sexual Dysfunction Assessment and Managment of Vaginismus
Botox for the Treatment of Recurrent Chronic Exertional Compartment Syndrome
Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity
DWP450 for Treating Moderate to Severe Glabellar Lines
Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines
Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 95